Cargando…

Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression

BACKGROUND: To evaluate the anatomic site(s) of initial disease progression in patients with castration resistant metastatic prostate cancer (mCRPC) in the presence or absence of pre-treatment visceral metastases while on systemic therapy. METHODS: This is a retrospective cohort study of mCRPC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruchalski, Kathleen, Kim, Hyun J., Douek, Michael, Raman, Steven, Patel, Maitraya, Sai, Victor, Gutierrez, Antonio, Levine, Benjamin, Fischer, Cheryce, Allen-Auerbach, Martin, Gupta, Pawan, Coy, Heidi, Villegas, Bianca, Brown, Matthew, Goldin, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281063/ https://www.ncbi.nlm.nih.gov/pubmed/35836271 http://dx.doi.org/10.1186/s40644-022-00469-z

Ejemplares similares

Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer
por: Brown, Matthew S., et al.
Publicado: (2018)

Crítica literaria actual : método y sistema
por: Coy, Juan José
Publicado: (1966)

Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
por: Meyer, Andrew, et al.
Publicado: (2012)

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Current perspectives on bone metastases in castrate-resistant prostate cancer
por: Logothetis, Christopher, et al.
Publicado: (2018)

Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer
por: Koie, Takuya, et al.
Publicado: (2020)

Panorama de la filosofía iberoamericana actual
por: Villegas, Abelardo
Publicado: (1963)

Extensive necrosis of visceral melanoma metastases after immunotherapy
por: Stoeter, David, et al.
Publicado: (2008)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer
por: Cox, Heather, et al.
Publicado: (2015)

PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma
por: Harris, Nathanial, et al.
Publicado: (2023)

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?
por: Hu, Ye, et al.
Publicado: (2020)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

A Medley of Midbrain Maladies: A Brief Review of Midbrain Anatomy and Syndromology for Radiologists
por: Ruchalski, Kathleen, et al.
Publicado: (2012)

Imaging response assessment for oncology: An algorithmic approach
por: Ruchalski, Kathleen, et al.
Publicado: (2022)

Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013)

Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
por: Gater, Adam, et al.
Publicado: (2011)

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
por: Zhang, Xiaotun, et al.
Publicado: (2011)

Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride
por: Lien, Lise Marie E, et al.
Publicado: (2015)

Diagnostic Value of Molecular Testing in Sonographically Suspicious Thyroid Nodules
por: Wang, Maxwell M, et al.
Publicado: (2020)

Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide
por: Kumano, Yohei, et al.
Publicado: (2019)

Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
por: La Vecchia, Maria, et al.
Publicado: (2022)

Visceral Metastasis: A Prognostic Factor of Survival in Patients with Spinal Metastases
por: Lun, Deng‐xing, et al.
Publicado: (2020)

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma
por: Papp, Orsolya, et al.
Publicado: (2021)

Risk factors of developing visceral metastases at diagnosis in prostate cancer patients
por: Xu, Ning, et al.
Publicado: (2019)

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
por: Lorente, David, et al.
Publicado: (2016)

Case Series: “Silent” Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer
por: Sabanathan, Dhanusha, et al.
Publicado: (2023)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
por: Tallet, Agnes V, et al.
Publicado: (2012)

Actual, Personalized Approaches to Preserve Cognitive Functions in Brain Metastases Breast Cancer Patients
por: Konopka-Filippow, Monika, et al.
Publicado: (2022)

Efficacy of MR-guided focused ultrasound ablation for localized adenomyosis in comparison to leiomyoma
por: Coy, Heidi, et al.
Publicado: (2015)

Docetaxel Rechallenge in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer: A Case Report and Review of Literature
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2023)

Gynecologic tumor board: a radiologist’s guide to vulvar and vaginal malignancies
por: Chow, Lucy, et al.
Publicado: (2021)

Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2021)

The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer
por: Ranasinghe, Weranja K B, et al.
Publicado: (2014)

A rare case of isolated castrate resistant bilateral testicular metastases in advanced prostate cancer
por: Su, Jiarui, et al.
Publicado: (2018)

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases
por: Kapoor, Anil, et al.
Publicado: (2019)

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence
por: Rabbie, Roy, et al.
Publicado: (2020)

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy
por: Dupuy, Laura, et al.
Publicado: (2011)

Pretreatment neutrophil‐to‐lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration‐sensitive prostate cancer
por: Salah, Samer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dag1a2lcfqfpq92afvj0tja1qj